A Multi-country, Cross-sectional Quantitative Study Exploring Awareness, Understanding, and Perceptions of the Relation Between Cardiorenal Metabolic Conditions and MASLD/MASH Among Healthcare Providers, People With MASLD/MASH, and At-risk Population

Clinical trial NCT07201831 · COMPLETED

Trial details

NCT number: NCT07201831
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Study type: OBSERVATIONAL

Metabolic Dysfunction-associated Steatohepatitis (MASH)

Start date: 2025-10-02
Primary completion: 2026-01-17
Enrollment: 1330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.